Insider · CIK 0001523522

Nielsen Kirk G.

Reports to the SEC for 3 companies · MINNEAPOLIS, MN

sec.gov

Transactions

Companies

Filings

CIK

0001523522

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	CVRXCVRx, Inc.A Award	Director	AAward	+8,720 sh	—	—	8,720
2026-06-01	CVRXCVRx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.2K sh	—	—	11,182
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director	CConversion	+1.69M sh	—	—	1,690,230
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director	CConversion	+548K sh	—	—	2,238,297
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director	CConversion	+548K sh	—	—	2,786,364
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	Director	CConversion	+359K sh	—	—	3,145,619
2026-02-09	SGPSpyGlass Pharma, Inc.P Purchase	Director	PPurchase	+165K sh	$16.00	+$2.64M	3,310,619
2026-02-09	SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−9.69M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion	Director	CConversion	−3.14M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion	Director	CConversion	−3.14M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion	Director	CConversion	−2.06M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−1.69M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion	Director	CConversion	−548K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion	Director	CConversion	−548K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion	Director	CConversion	−359K sh	—	—	0
2026-02-05	SGPSpyGlass Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.4K sh	—	—	27,400
2025-06-03	CVRXCVRx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.6K sh	—	—	19,554
2025-05-15	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+11K sh	$5.45	+$59.8K	1,910,134
2025-05-14	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+61.2K sh	$5.23	+$320K	1,899,168
2025-05-13	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+101K sh	$5.29	+$536K	1,837,968
2025-05-12	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+25.2K sh	$4.79	+$121K	1,736,555
2024-06-04	CVRXCVRx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21K sh	—	—	20,961
2024-06-04	CVRXCVRx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.3K sh	—	—	27,250
2023-06-05	CVRXCVRx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,012
2023-05-27	Inari Medical, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,982 sh	—	—	61,479
2023-05-27	Inari Medical, Inc.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,982 sh	—	—	0
2023-05-18	Inari Medical, Inc.A Award	Director	AAward	+2,412 sh	—	—	58,497
2022-06-07	CVRXCVRx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27K sh	—	—	26,985
2022-05-27	Inari Medical, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,983 sh	—	—	56,085
2022-05-27	Inari Medical, Inc.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,983 sh	—	—	2,982
2022-05-26	Inari Medical, Inc.A Award	Director	AAward	+2,420 sh	—	—	53,102
2022-05-24	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+8,070 sh	$5.05	+$40.8K	1,711,355
2022-05-23	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+4,432 sh	$5.04	+$22.3K	1,703,285
2022-05-20	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+13.4K sh	$5.04	+$67.4K	1,698,853
2022-05-19	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+11K sh	$5.04	+$55.3K	1,685,466
2022-05-05	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+3,992 sh	$6.00	+$23.9K	1,674,490
2022-05-04	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+25.5K sh	$5.99	+$153K	1,670,498
2022-05-03	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+32.8K sh	$6.00	+$197K	1,644,995
2022-05-02	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+42K sh	$5.97	+$251K	1,612,186
2022-04-28	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+100 sh	$5.97	+$597	1,570,198
2022-02-24	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+3,400 sh	$8.24	+$28K	1,570,098
2022-02-23	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+38.2K sh	$8.04	+$307K	1,566,698
2022-02-22	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+40K sh	$7.94	+$318K	1,528,498
2022-02-18	CVRXCVRx, Inc.P Purchase	Director	PPurchase	+26.7K sh	$7.92	+$211K	1,488,490
2021-07-02	CVRXCVRx, Inc.C Conversion	Director	CConversion	+1.46M sh	—	—	1,461,831
2021-07-02	CVRXCVRx, Inc. · Series G Preferred StockC Conversion	Director	CConversion	−23.1M sh	—	—	0
2021-06-29	CVRXCVRx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.4K sh	—	—	10,382
2021-05-27	Inari Medical, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,982 sh	—	—	49,302
2021-05-27	Inari Medical, Inc.A Award	Director	AAward	+1,380 sh	—	—	50,682
2021-05-27	Inari Medical, Inc.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,982 sh	—	—	5,965

Recent filings

Accepted (ET)
Jun 34
Nielsen Kirk G.0001523522-26-000007
SEC(opens sec.gov)
Feb 114/A
Nielsen Kirk G.0001193125-26-046833
SEC(opens sec.gov)
Feb 104
Nielsen Kirk G.0001193125-26-045029
SEC(opens sec.gov)
Feb 94
Nielsen Kirk G.0001523522-26-000004
SEC(opens sec.gov)
Jun 54
Nielsen Kirk G.0001415889-25-015816
SEC(opens sec.gov)
May 194
Nielsen Kirk G.0000950170-25-074682
SEC(opens sec.gov)
May 144
Nielsen Kirk G.0000950170-25-071629
SEC(opens sec.gov)

Companies

Address

9201 WEST BROADWAY AVE SUITE 650

MINNEAPOLIS, MN, 55445